Medlab Clinical (ASX:MDC) Net Margin % : -4,127.08% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Medlab Clinical Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Medlab Clinical's Net Income for the six months ended in Dec. 2023 was A$-1.98 Mil. Medlab Clinical's Revenue for the six months ended in Dec. 2023 was A$0.05 Mil. Therefore, Medlab Clinical's net margin for the quarter that ended in Dec. 2023 was -4,127.08%.

The historical rank and industry rank for Medlab Clinical's Net Margin % or its related term are showing as below:

ASX:MDC' s Net Margin % Range Over the Past 10 Years
Min: -1152.92 Med: -241.56 Max: -110.41
Current: -1152.92

ASX:MDC's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -152.785 vs ASX:MDC: -1152.92

Medlab Clinical Net Margin % Historical Data

The historical data trend for Medlab Clinical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Net Margin % Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Margin %

Get a 7-Day Free Trial

-148.95

-470.47

-280.15

-558.66

-759.87

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial												-702.30	-484.32	-805.35	-667.35	-4,127.08

Competitive Comparison of Medlab Clinical's Net Margin %

For the Biotechnology subindustry, Medlab Clinical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's Net Margin % falls into.

Medlab Clinical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Medlab Clinical's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-6.778	/	0.892
	=	-759.87 %

Medlab Clinical's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.981	/	0.048
	=	-4,127.08 %

Medlab Clinical (ASX:MDC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Medlab Clinical Net Margin % Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (ASX:MDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (ASX:MDC) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.